| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Thomas A McCarthy is Director at PRVA and has filed Form 4s across 2 companies. Thomas A McCarthy's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.2M at current prices.
The biggest single holding is PRVA (~$601K) as Director. Net of sales, the PRVA filings show accumulation of 10,000 shares.
Thomas A McCarthy has 19 Form 4 filings on record from May 2018 to May 2026, across 2 companies: Director at Privia Health Group (PRVA), 2021–2026; Director at Selective Insurance Group (SIGI), 2018–2026.
The 22 reported transactions were 16 stock awards, 4 gifts and 2 open-market purchases.
Counted by filing, the open-market trades come to 2 purchases worth about $357K and no sales.
The largest open-market purchase was 2,500 shares of SIGI at an average $77.42 on July 28, 2025, about $194K. Twelve months later SIGI was up 20%.